Skip to content
Screener

MiMedx Group MDXG Reportable Segment — Interest Income

Similar metrics at other companies

Veradermics logo
MANEReportable Segment — Interest Income
$2.5M+400%
Bicara Therapeutics logo
BCAXReportable Segment — Interest Income
$4.08M-18.6%
nCino, Inc. logo
NCNOReportable Segment — Interest Income
$366K-12.2%
DocuSign logo
DOCUReportable Segment — Interest Income
$8.73M-18.4%
UiPath logo
PATHReportable Segment — Interest Income
$10.4M-17.8%
YSS
YSSReportable Segment — Interest Income
$4.62M+754%

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$622.4M-40.2%
Enterprise value$503.76M-46.5%
P/E99.8×+67.4×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income$1,174$1,213$2,460$2,197
Interest expense(386)(475)(787)(953)
Interest income, net$788$738$1,673$1,244

Item 1. Financial Statements

FAQ

What is MiMedx Group's reportable segment — interest income?
MiMedx Group (MDXG) reported reportable segment — interest income of $1.17M in Q2 2026.
What does reportable segment — interest income mean?
This metric represents the revenue generated from interest-bearing assets, such as cash equivalents or short-term investments, specifically attributed to a reportable business segment. It reflects the segment's ability to earn a return on its allocated capital or excess liquidity. This is a key indicator of the segment's financial management and its contribution to non-operating income.

Ask your AI about MiMedx Group's reportable segment — interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude